A Phase Ib Study of the Safety and Pharmacology of Atezolizumab (MPDL3280A) Administered with Erlotinib or Alectinib in Patients with Advanced Non−Small Cell Lung Cancer
Cancer - Lung
Sai-Hong Ignatius Ou
Alectinib, Atezolizumab, Erlotinib, MPDL3280A, OSI-774, Tarceva
For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email firstname.lastname@example.org.